Annis Gardner Whiting Capital Advisors, LLC Novartis Ag Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $485 Billion
- Q3 2025
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 354 shares of NVS stock, worth $46,568. This represents 0.01% of its overall portfolio holdings.
Number of Shares
354
Previous 476
25.63%
Holding current value
$46,568
Previous $57.6 Million
21.19%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,618Shares Held
136MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...